Appropriate Use of Proton Pump Inhibitor in Inpatients of Cen tral Army Gatot Soebroto Hospital
1, 1, 2, 1★★ Corresponding author
- 1Clinical Pharmacy Department, Faculty of Pharmacy, Universitas Indonesia, INDONESIA.
- 2Gatot Soebroto Army Center Hospital, INDONESIA.
CORRESPONDENCE
Retnosari Andrajati
Clinical Pharmacy Department, Faculty of Pharmacy, Universitas Indonesia, INDONESIA.
Received: 20-01-2017; Revised: 21-01-2017; Accepted: 18-02-2017.
Volume 9, Issue 1s · pp. s9-s12 · 2017 · DOI: 10.5530/jyp.2017.1s.3
ABSTRACT
Background: Evaluation of the use of Proton Pump Inhibitors (PPIs) perceiving the high use of PPIs and likely impacts from inappropriate use of PPPs. The aim of this study was to evaluate the use of PPI on in-patients at Gatot Soebroto Army Center Hospital.Material and Methods: the study design was observa tional analytic descriptive with prospective data collection method base on pre scription and medical record. The sample was data of entire adult in-patients with Indonesian National Health Insurance who used PPI at Internal Diseases Department. PPI use was evaluated based on rationality and therapy effective ness.Results: Analysis carried out on 153 PPIs therapy of 91 in-patients. The percentages of PPIs therapies with appropriate indication was 77.78%, appro priate drug selection was 77.78%, appropriate patient condition was 98.69%, appropriate dose was 4.58%, appropriate therapy duration was 66.01% and therapy effectiveness was 86.27%. Only 3.92% PPIs therapies were rational regarding all the appropriate criteria fulfillness.Conclusion: Monitoring and evaluation of PPIs use should be done for attaining properly outcome.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Anindita, M., Syafhan, N. F., Hersunaryati, Y., & Andrajati, R. (2017). Appropriate Use of Proton Pump Inhibitor in Inpatients of Cen tral Army Gatot Soebroto Hospital. Journal of Young Pharmacists, 9(1s), s9-s12. https://doi.org/10.5530/jyp.2017.1s.3
Copyright and licence
© 2017 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0
